«CHLORAMBUCIL»に関連する英語の本
以下の図書目録から
chlorambucilの使いかたを見つけましょう。
chlorambucilに関する本と英語文献で使われた文脈を提供するための簡単な抜粋文。
1
Comprehensive Geriatric Oncology, Second Edition
Many alkylating agents, including mechlorethamine, triethylenemelamine,
busulfan, chlorambucil, and cyclophosphamide, have been used in the treatment
of CLL, but only chlorambucil and cyclophosphamide have remained in regular, ...
Lodovico Balducci, William B. Ershler, Gary H. Lyman, 2004
2
Withrow and MacEwen's Small Animal Clinical Oncology
Box 31-4 Treatment of Chronic Lymphocytic Leukemia Regimen 1 Chlorambucil,
0.2 mg/kg, PO, days 7-14; then 0.1 mg/kg, PO, continuously or 2 mg/m2, PO, QOD
* Prednisone, 30 mg/m2, PO, SID, for 7 days; then 20 mg/m2, PO, SID, for 7 ...
Stephen J. Withrow, David M. Vail, 2007
3
Drugs in Pregnancy and Lactation: A Reference Guide to Fetal ...
A Reference Guide to Fetal and Neonatal Risk Gerald G. Briggs, Roger K.
Freeman, Sumner J. Yaffe. 12:47 C PREGNANCY SUMMARY The limited data
suggest that chlorambucil is a human teratogen.
Gerald G. Briggs, Roger K. Freeman, Sumner J. Yaffe, 2012
4
The AARP Guide to Pills: Essential Information on More Than ...
head injury • infection (especially virus infection such as chick- enpox or herpes) •
kidney disease • recent radiation therapy • seizures (convulsions) • an unusual or
allergic reaction to chlorambucil, other chemotherapy, other medicines, foods, ...
5
Clinical Trials in Rheumatology
Trial Immunosuppression with Chlorambucil, versus placebo, for scleroderma.
Results of a three-year, parallel, randomized, double-blind study Substance
Placebo (n = 32) 0.05 mg/kg chlorambucil/day (n = 33) 0.075 mg/kg chlorambucil/
day ...
Ruediger Mueller, Johannes von Kempis, 2010
6
Eighth Annual Report on Carcinogens: 1998 Summary
Excesses of leukemia were reported in a number of epidemiological studies in
which chlorambucil, either alone or in combination with other therapies, was
used in treating nonmalignant and malignant diseases. Other cancers have also
been ...
7
Report on Carcinogens (12th Ed. )
In an initiation-promotion study, chlorambucil acted as a skin-tumor initiator when
croton oil was used as the promoter (IARC 1981, 1987). The Internatioal Agency
for Research on Cancer (IARC 1987) concluded that there was sufficient ...
Nat. Toxicology Program (NTP) (NIH), 2011
8
Mass Spectrometry in Cancer Research
Chlorambucil has a cytotoxic metabolite, phenylacetic mustard, 2-[4-N,N-bis(2-
chloroethyl)ami- nophenyl] acid (PAM), that is formed at the butyric acid side-
chain by p-oxidation. A GC/EIMS technique was developed for the quantification
of ...
9
Wintrobe's Clinical Hematology
response rAtes In CHronIC LyMpHoCytIC LeukeMIA (CLL) to DIfferent
CHLorAMbuCIL reGIMens taBLe 90.10 Total chlorambucil PFS Author
Chlorambucil Schedule per month (mg)a CR (%) PR (%) (Months) Rai (2000)429
40 mg/m2 every ...
John P. Greer, Daniel A. Arber, Bertil Glader, 2013
69 Tessler HH, Jennings T: High-dose short-term chlorambucil for intractable
sympathetic ophthalmia and Behc ̧et's disease. Br J Ophthalmol 1990;74:353–
357. 70 Kaul S, Goldstein DA, Carnahan MC, Shain O, Tessler HH: Long-term ...
用語«CHLORAMBUCIL»を含むニュース項目
国内外の報道機関が語った内容や、次のニュース項目の文脈から
chlorambucilという用語がどのように使われているかを調べてみましょう。
Genmab Announces European Regulatory Submission for …
In the United States, Arzerra is approved for use in combination with chlorambucil for the treatment of previously untreated patients with CLL for ... «GlobeNewswire, 7月 15»
Patients in Manitoba and Saskatchewan living with the most …
Earlier this week, GAZYVA® (obinutuzumab) in combination with chlorambucil chemotherapy was added to benefits formularies of the ... «NEWS.GNOM.ES, 7月 15»
Familial chronic lymphocytic leukemia in two siblings with ATM …
... progressed again and proved refractory to all therapeutic agents administered (including the R-CHOP regimen, chlorambucil/prednisolone, ... «Nature.com, 7月 15»
Society for Immunotherapy of Cancer Reacts to EMA Approval of …
... by the U.S. FDA for treating rare (many considered “immunogenic”) cancers, including: obinutuzumab + chlorambucil and ofatumumab + chlorambucil (chronic ... «PR Web, 6月 15»
Afternoon Trade News Analysis on: Gilead Sciences, (NASDAQ …
... randomized 2:1 to receive either REVLIMID (n=170) or single agent cytarabine, rituximab, gemcitabine, fludarabine or chlorambucil (n=84). «wsnewspublishers, 6月 15»
Dr. Atanasio on Ibrutinib and Obinuzutumab Combination in CLL/SLL
Previous studies show that the combination of chlorambucil with obinutuzumab improved progression-free and overall survival in patients with ... «OncLive, 6月 15»
Clinical Conundrums
False; Obinutuzumab (Gazyva, Genentech) is a type 2, glycoengineered, anti-CD20 antibody recently approved for use with chlorambucil for ... «Clinical Oncology News, 6月 15»
Dr. Adrian Wiestner on RESONATE II Trial
Preliminary results from the trial show an improved overall survival and overall response rate with ibrutinib when compared to chlorambucil. «OncLive, 6月 15»
Pre-Market News Analysis on: Celgene (NASDAQ:CELG), Teva …
... randomized 2:1 to receive either REVLIMID (n=170) or single agent cytarabine, rituximab, gemcitabine, fludarabine or chlorambucil (n=84). «wsnewspublishers, 6月 15»
Hot Biotech Stocks On Radar - Novavax (NASDAQ:NVAX), Celgene …
... randomized 2:1 to receive either REVLIMID (n=170) or single agent cytarabine, rituximab, gemcitabine, fludarabine or chlorambucil (n=84). «Wall Street Observer, 6月 15»
